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Abstract: Polymyalgia Rheumatica (PMR) presents with a broad spectrum of clinical manifestations and almost exclusively occurs 
in the population aged over 50 years. After rheumatoid arthritis, PMR is the second most common autoimmune rheumatic 
disorder. Visual loss is the most feared complication in temporal arteritis, and extracranial arteries. No specific laboratory 
parameter exists for diagnosis of PMR. 
Imaging techniques such as ultrasonography, MRI or F-fluorodeoxyglucose PET may be helpful in the diagnosis and evaluation of 
the extent of vascular involvement in these diseases. This paper presets an expert system for classification criteria for PMR, recent 
advances of diagnostic and therapeutic procedures. This expert System was written using SL5 Object Expert System Language. 
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1. INTRODUCTION 
PMR is characterized by pain and stiffness in the proximal regions of the extremities and neck, and elevated markers of 
inflammation [2]. GCA may present with a broad spectrum of clinical manifestations that are either attributable to a systemic 
inflammatory response, including fever, weight loss or anemia, or to local complications of vascular injury, such as headache, visual 
symptoms or limb claudicating. 
Polymyalgia rheumatica is a typical disease of the elderly and are among the most common indications for prolonged corticosteroid 
therapy in this population. While treatment-associated complications are the most significant factors contributing to long-term 
morbidity of PMR patients. 
Expert System is a computer application of Artificial Intelligence (AI), which contains a knowledge base and an inference engine, 
the main components and details are represented in figure[23-30]. 
 
Figure 1: The figure presents the Main Components of an Expert System, Designed by the authors. 
The proposed Expert System for polymyalgia rheumatica Diseases Diagnosis was implemented using SL5 Object language 
which stands for Simpler Level 5 Object [21]. It is a forward chaining reasoning expert system that can make inferences about facts 
of the world using rules, objects and take appropriate actions as a result. The SL5 Object engine is implemented in Delphi 
Embarcadero RAD Studio XE6 [22]. SL5 Object executes any Expert System looks like frames.  It’s easy for the knowledge 
engineer to build the Expert System and for the end users when they use the system. 
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2. KNOWLEDGE REPRESENTATION 
Symptoms of polymyalgia rheumatic usually begin quickly and are worse in the morning. Most people who develop polymyalgia 
rheumatica are older than 65. It rarely affects people under 50 [1]. 
 
Figure 2:  present common clinical manifestations of PMR 
You may receive symptom relief by taking anti-inflammatory drugs called corticosteroids. But relapses are common, and you'll 
need to visit your doctor regularly to watch for serious side effects of these drugs [7]. 
Polymyalgia rheumatica is related to another inflammatory disorder called giant cell arteritis, which can cause headaches, vision 
difficulties, jaw pain and scalp tenderness. It's possible to have both of these conditions together. 
 
Figure 3:  The figure presents the PMR area of pain 
 Symptoms: 
The signs and symptoms of polymyalgia rheumatica usually occur on both sides of the body and may include [3]: 
 Aches or pain in your shoulders (often the first symptom) 
 Aches or pain in your neck, upper arms, buttocks, hips or thighs 
 Stiffness in affected areas, particularly in the morning or after being inactive for a long time 
 Limited range of motion in affected areas 
 Pain or stiffness in your wrists, elbows or knees (less common) 
 
You may also have more general signs and symptoms, including: 
 Mild fever 
 Fatigue 
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 A general feeling of not being well (malaise) 
 Loss of appetite 
 Unintended weight loss 
 Depression 
 
Figure 4:  the figure present signs and symptoms of PMR 
Causes: 
The exact cause of polymyalgia rheumatica is unknown. Two factors appear to be involved in the development of this condition 
[18- 19]: 
 Genetics. Certain genes and gene variations may increase your susceptibility. 
 An environmental exposure. New cases of polymyalgia rheumatica tend to come in cycles and may develop seasonally. This 
suggests that an environmental trigger, such as a virus, might play a role. But no specific virus has been shown to cause 
polymyalgia rheumatica. 
Giant cell arteritis 
Polymyalgia rheumatica and another disease known as giant cell arteritis share many similarities. Giant cell arteritis results in 
inflammation in the lining of arteries, most often the arteries located in the temples. Giant cell arteritis can cause headaches, jaw 
pain, vision problems and scalp tenderness. If left untreated, it can lead to stroke or blindness. 
Polymyalgia rheumatica and giant cell arteritis may actually be the same disease but with different manifestations. The overlap 
between the two diseases is significant: 
 About 20 percent of people with polymyalgia rheumatica also have signs and symptoms of giant cell arteritis. 
 About half of the people with giant cell arteritis may also have polymyalgia rheumatica. 
 
Risk factors for polymyalgia rheumatica include: 
 Age. Polymyalgia rheumatica affects older adults almost exclusively. The average age at onset of the disease is 73. 
 Sex. Women are about two times more likely to develop the disorder. 
 Race and geographic region. Polymyalgia rheumatica is most common among whites in northern European populations. 
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Complications 
Symptoms of polymyalgia rheumatica can greatly affect your ability to perform everyday activities. The pain and stiffness may 
contribute to difficulties with tasks such as the following: 
 Getting out of bed, standing up from a chair or getting out of a car 
 Bathing or combing your hair 
 Getting dressed or putting on a coat 
These difficulties can affect your health, social interactions, physical activity, sleep and general well-being [2-3] . 
In addition, people with polymyalgia rheumatica seem to be more likely to develop peripheral arterial disease EX giant cell arteritis 
[4]. 
 
Figure 5:  figure shows the difference between GCA & normal artery 
 
Tests and exams  
Your answers to questions, a general physical exam and the results of tests can help your doctor determine the cause of your pain 
and stiffness. This diagnostic process also helps your doctor rule out other disorders that have similar symptoms to polymyalgia 
rheumatica. 
Your doctor may reassess your diagnosis as your treatment progresses. Studies show that 2 to 30 percent of people initially given 
a diagnosis of polymyalgia rheumatica were later reclassified as having rheumatoid arthritis. 
Exam 
Your doctor will conduct an exam to get an idea of your overall health, identify possible causes or rule out certain diseases. He or 
she may gently move your head and limbs to assess whether your symptoms affect your range of motion. 
Blood tests 
A nurse or assistant will draw a sample of your blood. This sample will be used for several laboratory tests that your doctor will 
order. Typically, your doctor will check the complete blood counts (CBC) and two indicators of inflammation — sed rate 
(erythrocyte sedimentation rate) and C-reactive protein. 
Imaging tests 
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Increasingly, ultrasound is being used to distinguish polymyalgia rheumatica from other conditions that cause similar symptoms. 
Magnetic resonance imaging (MRI) can also identify other causes of shoulder pain, such degenerative joint changes. 
Monitoring for giant cell arteritis 
Your doctor will monitor you for signs and symptoms that may indicate the onset of giant cell arteritis. Talk to your doctor 
immediately if you experience any of the following: 
 New, unusual or persistent headaches 
 Jaw pain or tenderness 
 Blurred or double vision or visual loss 
 Scalp tenderness 
If your doctor suspects you may have giant cell arteritis, he or she will likely order a biopsy of the artery in one of your temples. 
This procedure, performed during local anesthesia, removes a tiny sample of the artery, which is then examined in a laboratory for 
signs of inflammation [12]. 
Treatments and drugs 
Treatment usually involves medications to help ease your symptoms. Relapses are common. 
Corticosteroids 
Polymyalgia rheumatica is usually treated with a low dose of an oral corticosteroid, such as prednisone. A daily dose at the 
beginning of treatment is usually 12 to 25 milligrams a day [5]. 
You'll likely start to feel relief from pain and stiffness within the first two or three days. If you aren't responding to treatment, 
your doctor may refer you to a rheumatologist. 
After the first two to four weeks of treatment, your doctor may begin to gradually decrease your dosage depending on your 
symptoms and the results of blood tests. The goal is to keep you on as low a dose as possible without triggering a relapse in your 
symptoms. 
Most people with polymyalgia rheumatica need to continue the corticosteroid treatment for at least a year. You'll need frequent 
follow-up visits with your doctor to monitor how the treatment is working and whether you're having any side effects. 
People who taper off the medication too quickly are more likely to have a relapse. Thirty to 60 percent of people with 
polymyalgia rheumatica will have at least one relapse when tapering off the corticosteroids. Relapses (flares) are treated by 
increasing your drug dosage for a while then tapering again. 
 
Figure 6: The figure present diagnosing PMR, comprehension between classical & typical PMR 
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Monitoring side effects 
Long-term use of corticosteroids can result in a number of serious side effects. Your doctor will monitor you closely for 
problems. He or she may adjust your dosage and prescribe treatments to manage these reactions to corticosteroid treatment. Possible 
side effects include: 
 Weight gain 
 Osteoporosis — the loss of bone density and weakening of bones 
 High blood pressure (hypertension) 
 Diabetes 
 Cataracts — a clouding of the lenses of your eyes 
Calcium and vitamin D supplements 
Your doctor will likely prescribe daily doses of calcium and vitamin D supplements to help prevent bone loss induced by 
corticosteroid treatment. The American Academy of Rheumatology recommends the following daily doses for anyone taking 
corticosteroids: 
 1,200 to 1,500 milligrams (mg) of calcium supplements 
 800 to 1,000 international units (IU) of vitamin D supplements 
Pneumonia vaccine 
Your doctor may suggest you get a pneumonia vaccine if you are taking 20 milligrams or more of prednisone a day. 
Methotrexate (Trexall) 
Joint guidelines from the American Academy of Rheumatology and the European League Against Rheumatism suggest using 
Methotrexate with corticosteroids in some patients. This is an immune-suppressing medication that is taken by mouth. It may be 
useful early in the course of treatment or later, if you relapse or don't respond to corticosteroids. 
Physical therapy 
You may benefit from physical therapy if you've had a long stretch of limited activity owing to polymyalgia rheumatica. Talk 
with your doctor about whether physical therapy is a good option for you if you're trying to regain strength, coordination and the 
ability to perform everyday tasks. 
Over-the-counter no steroidal anti-inflammatory drugs, such as ibuprofen (Advil, Motrin, others) or naproxen (Aleve), are not 
usually recommended for easing the signs and symptoms of polymyalgia rheumatica. 
Healthy lifestyle choices can help you manage the side effects that may result from corticosteroid treatment: 
 Eat a healthy diet. Eat a diet of fruits, vegetables, whole grains, and low-fat meat and dairy products. Limit the salt 
(sodium) in your diet to prevent fluid buildup and high blood pressure. 
 Exercise regularly. Talk to your doctor about exercise that is appropriate for you to maintain a healthy weight and to 
strengthen bones and muscles. 
 Use assistive devices. Use luggage and grocery carts, reaching aids, shower grab bars and other assistive devices to help 
make daily tasks easier. Take steps to minimize the risk of falls, such as wearing low-heeled shoes. Talk to your doctor 
about whether the use of a cane or other walking aid is appropriate for you to prevent falls or other injury. 
 
3. LITERATURE REVIEW  
Many expert systems have been designed [23-52] to help facilitating diagnosing and managing a lot of diseases and medical 
problems which considered as a part of applying Artificial Intelligence and computer science in order to help doctors, hospitals and 
health care facilities decision making to enable them to offer their health services in the correct way. The current Expert System is 
designed for diagnosing Polymyalgia Rheumatic problems and recommends the proper treatment.  
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4. MATERIALS AND METHODS  
The proposed expert system performs the diagnosis of Polymyalgia Rheumatic problems by asking questions that requires 
Yes/No answers. The proposed expert system will ask the user to choose the correct answer in each screen. At the end of the 
diagnosis session, the proposed expert system provides the proper diagnosis of the problem and gives a recommendation for the 
treatment to the users. Figure 2 shows the first screen of the expert system session. Figure 2 shows a question from the dialogue 
between the user and the expert system, and Figure 3 shows how the expert system displays the diagnosis of the problem and the 
recommendation for treating the patient. 
 
 
Figure 7: The figure shows the starting screen of the expert system.  
 
Figure 8: The figure shows when the system asks the user. 
 
Figure 9: The figure shows diagnosis and recommendation of the expert system. 
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5. CONCLUSION 
Polymyalgia rheumatica is a common disease in the elderly. New classification criteria for PMR have recently been presented 
and will facilitate future studies on treatment and outcome of this disease.  
In this research we have tried our best to help people to diagnose themselves with the aid of specialized expert system for 
Polymyalgia rheumatic. This expert system is easy to use and has a user friendly interface. 
 
6. EXPERT SYSTEM SOURCE CODE 
! Polymyalgia Rheumatica        
ATTRIBUTE Do you have fatigue ?  COMPOUND 
Yes, No 
 
ATTRIBUTE Do you have malaise ?  COMPOUND   
Yes, No 
 
ATTRIBUTE Did you feel any fever ?  COMPOUND 
Yes, No 
 
ATTRIBUTE Did you have a sudden weight loss ?  COMPOUND 
Yes, No  
 
ATTRIBUTE Did you have loss of appetite ?  COMPOUND 
Yes, No 
 
ATTRIBUTE Did your red blood cell account low ?  COMPOUND 
Yes, No 
 
ATTRIBUTE Did your ESR result high ?  COMPOUND 
Yes, No 
 
ATTRIBUTE Did you have positive CRP & RF ?  COMPOUND 
Yes, No 
 
ATTRIBUTE Did you feel a limited range of motion ?  COMPOUND 
Yes, No 
 
ATTRIBUTE start SIMPLE  
 
 INSTANCE the domain ISA domain 
 WITH start := TRUE 
 
INSTANCE the application ISA application 
 WITH title display := introduction 
 WITH conclusion display :=  Conc 
 WITH numeric precision := 8 
 WITH simple query text := "Is it true that: 
  WITH numeric query text := "What is(are): 
  WITH string query text := "What is(are): 
  WITH time query text := "What is(are): 
  WITH interval query text := "What is(are): 
  WITH compound query text := " 
  WITH multicompound query text := "What is(are): 
 
INSTANCE introduction ISA display 
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  WITH wait := TRUE 
  WITH delay changes := FALSE 
  WITH items [1 ] := textbox 1 
 
INSTANCE textbox 1 ISA textbox 
  WITH location := 10,10,800,350 
  WITH pen color := 0,0,0 
  WITH fill color := 100,200,100 
  WITH justify IS left 
  WITH font := "Arial" 
  WITH font style IS bold 
  WITH font size := 14 
 WITH text "=: 
Polymyalgia Rheumatic Expert System Diagnoses  Written By Massoud El Agha, and Abdallah Jarghon 
This Expert system is an example of Simpler Level 5 Object (SL5 Object) that Demonstrate the use of some of the System classes, 
Instances, Rules, etc. 
This Expert System diagnoses Polymyalgia Rheumatic Problems through a dialogue between the 
System and the End User. 
The Conclusion of the finding is displayed and an Advise is given for the End User to solve the problem". 
 
INSTANCE Conc ISA display 
  WITH wait := TRUE 
  WITH delay changes := FALSE 
  WITH items [1] := title textbox 
  WITH items [2 ] := problem textbox 
  WITH items [3 ] := advise textbox 
 
INSTANCE title textbox ISA textbox 
  WITH location := 20,10,800,70 
  WITH pen color := 0,0,0 
  WITH fill color := 200,200,100 
  WITH justify IS center 
  WITH font := "Arial" 
  WITH font style IS bold 
  WITH font size := 14 
  WITH text := " The Conclusion of the Expert System" 
 
INSTANCE problem textbox ISA textbox 
  WITH location := 20,110,800,130 
  WITH pen color := 0,0,0 
  WITH fill color := 170,170,170 
  WITH justify IS left 
  WITH font := "Arial" 
  WITH font size := 14 
   WITH text :=" --===--" 
 
INSTANCE advise textbox ISA textbox 
  WITH location := 20,280,800,130 
  WITH pen color := 0,0,0 
  WITH fill color := 170,170,170 
  WITH justify IS left 
  WITH font := "Arial" 
  WITH font size := 14 
  WITH text :=" --===--" 
 
RULE R0 
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IF start 
THEN ASK Do you have fatigue ? 
 
RULE R1 
IF Do you have fatigue ? IS Yes 
THEN ASK Do you have malaise ? 
 
RULE R1a 
IF Do you have fatigue ? IS No 
THEN ASK Did you feel any fever ? 
 
RULE R2 
IF Do you have malaise ? IS Yes 
THEN ASK Did you feel any fever ? 
 
RULE R2a 
IF Do you have malaise ? IS No 
THEN text OF problem textbox  := "you are healthy but you may have general weakness" 
AND text OF advise textbox := "Take your doctor right away." 
 
RULE R3 
IF  Did you feel any fever ? IS Yes 
THEN text OF problem textbox  := " your problem may aviral or bacterial infection" 
AND text OF advise textbox := "Take  your doctor right away." 
 
RULE R3a 
IF Did you feel any fever ?  IS No 
THEN  ASK Did you have a sudden weight loss ? 
 
RULE R4 
IF Did you have a sudden weight loss ? IS Yes 
THEN ASK Did you have loss of appetite ? 
 
RULE R4a 
IF Did you have a sudden weight loss ? IS No 
THEN text OF problem textbox  := " your problem may be a gastric infection" 
AND text OF advise textbox := "Take  your doctor right away." 
 
RULE R5 
IF Did you have loss of appetite ? IS Yes 
THEN ASK Did your red blood cell account low ? 
 
RULE R5a 
IF Did you have loss of appetite ? IS No 
THEN ASK Did your ESR result high ? 
 
RULE R6 
IF Did your red blood cell account low ? IS Yes 
THEN ASK Did your ESR result high ? 
 
RULE R6a 
IF Did your red blood cell account low ? IS No 
THEN text OF problem textbox  := " you must do some more test" 
AND text OF advise textbox := "Take  your doctor right away." 
 
RULE R7 
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IF Did your ESR result high ? IS Yes 
THEN ASK Did you feel a limited range of motion ? 
 
RULE R7a 
IF Did your ESR result high ? IS NoTHEN ASK Did you have positive CRP & RF ? 
 
RULE R8 
IF Did you have positive CRP & RF ? IS Yes 
THEN  text OF problem textbox  := " you may have an arthritis" 
AND text OF advise textbox := "Take  your doctor right away." 
 
RULE R8a 
IF Did you have positive CRP & RF ? IS No 
THEN ASK Did you feel a limited range of motion ? 
 
RULE R9 
IF Did you feel a limited range of motion ?  IS Yes 
THEN  text OF problem textbox  := " May be your problem is a polymalysia rheumatica See your doctor , avoid efforts & 
aggressive physical motion , do ESR and RCs frequently...." 
AND text OF advise textbox := "Take  your doctor right away." 
 
RULE R9a 
IF Did you feel a limited range of motion ?  IS No 
THEN  text OF problem textbox  := " Your problem may be an anemia" 
AND text OF advise textbox := "Take  your doctor right away." 
END 
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